Publications by authors named "Autumn Walkery"
Review of Allopregnanolone Agonist Therapy for the Treatment of Depressive Disorders.
Drug Des Devel Ther
December 2021
Article Synopsis
- The paper reviews the effectiveness and safety of allopregnanolone agonists, focusing on brexanolone and zuranolone for treating postpartum depression (PPD) and other depressive disorders.
- Both brexanolone and zuranolone show promise in significantly lowering depression scores compared to placebo, but common side effects like sedation and dizziness are noted.
- These medications may serve as quick solutions for PPD while potentially bridging to longer-term treatments like SSRIs, though further research is needed on their overall efficacy and application.